Saphris
Links shared publicly online about this topic
Saphris gains indications - MPR
empr.com — “Merck announced that Saphris (asenapine sublingual tablets) has been approved for two additional indications: 1) the maintenance treatment of schizophrenia and 2) as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.” View full resource at empr.com
Most Recently Shared on January 25, 2011 at 7:25 pm By:
MPR News: Saphris gains indications: Merck announced that Saphris (asenapine sublingual tablets) has been approv... http://bit.ly/i8jUas
Saphris gains indications - ONA
oncologynurseadvisor.com — “Merck announced that Saphris (asenapine sublingual tablets) has been approved for two additional indications: 1) the maintenance treatment of schizophrenia and 2) as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 25, 2011 at 7:47 pm By:
Saphris Approved for Schizophrenia and Bipolar Disorder
halifaxhealth.org — “Saphris Approved for Schizophrenia and Bipolar Disorder” View full resource at halifaxhealth.org
Most Recently Shared on August 14, 2009 at 7:37 pm By:
Saphris Approved for Schizophrenia and Bipolar Disorder http://bit.ly/XBhtu
Treatment With SAPHRIS® (asenapine) Sublingual Tablets
saphris.com — “SAPHRIS medication is commonly used to treat bipolar I disorder and schizophrenia in adults. Visit SAPHRIS and learn more about common symptoms and treatment.” View full resource at saphris.com
Most Recently Shared on July 15, 2010 at 5:44 pm By:
We're pleased and proud to announce the launch of http://www.saphris.com
Saphris approved for schizophrenia and bipolar I disorder - MPR
empr.com — “The FDA has approved Saphris (asenapine sublingual tablets, from Schering-Plough), a psychotropic agent, for the acute treatment of schizophrenia in adults and the acute treatment of manic or mixed episodes associated with bipolar I disorder with or without psychotic features in adults.” View full resource at empr.com
Most Recently Shared on August 14, 2009 at 3:41 pm By:
MPR News: Saphris approved for schizophrenia and bipolar I disorder: The FDA has approved Saphris (asen.. http://bit.ly/A4RkP
Schering-Plough Announces FDA Approval of Saphris (asenapine)
drugs.com — “Saphris (asenapine) is used to treat schizophrenia and bipolar I disorder. Includes Saphris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 15, 2009 at 6:07 am By:
Schering-Plough Announces FDA Approval of Saphris (asenapine) - http://bit.ly/XvAmd
Saphris Bipolar Medication | Atypical Antipsychotic | Bipolar Disorder For Dummies | Bipolar Beat
blogs.psychcentral.com — “Candida Fink, MD, discusses the use of a newer atypical antipsychotic called Saphris in treating bipolar mania.” View full resource at blogs.psychcentral.com
Most Recently Shared on September 9, 2010 at 3:10 pm By:
Bipolar Beat: Bipolar Disorder Medication Spotlight: Saphris http://bit.ly/bAdqvl
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder
medicalnewstoday.com — “The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder i” View full resource at medicalnewstoday.com
Most Recently Shared on August 16, 2009 at 12:35 pm By:
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder: The U.S. Food and Drug Adm.. http://bit.ly/ePdzL
FDA warns of allergy risk with Merck's antipsychotic Saphris | Reuters - Jack's posterous
pharmagossip.posterous.com — “FDA warns of allergy risk with Merck's antipsychotic Saphris | Reuters - Jack's posterous” View full resource at pharmagossip.posterous.com
Most Recently Shared on September 1, 2011 at 9:51 pm By:
FDA warns of allergy risk with Merck's antipsychotic Saphris | Reuters http://t.co/JTrprV3
FDA reports serious allergic reactions with Saphris use - - Drug Topics
drugtopics.modernmedicine.com — “FDA has issued a Safety Announcement warning that serious allergic reactions have been reported with the use of the antipsychotic medication asenapine maleate (Saphris).” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on September 1, 2011 at 10:51 pm By:
FDA reports serious allergic reactions with Saphris use http://t.co/hnKRMVm #bipolar
SAFETY ALERT: FDA Warns of Serious Allergic Reactions to Saphris - MPR
empr.com — “The FDA has notified healthcare professionals and patients that serious allergic reactions have been reported with the use of Saphris (asenapine; Merck).” View full resource at empr.com
Most Recently Shared on September 1, 2011 at 11:10 pm By:
SAFETY ALERT: FDA Warns of Serious Allergic Reactions to Saphris http://ow.ly/6jgX6 #mentalhealth
Saphris And Depression (Newest posts first) - The People's Medicine Community
prescriptiondrug-info.com — “I was given saphris for depression Saphris is a brand new drug but its labing is not for depression Has anyone else took this medicine ive been on a bunch of of meds for bipolar GAD and saphris worked the best for me i lost 30 lbs in 6 weeks im coming off of it cause it gave me tremors and i wait ta (Newest posts first)” View full resource at prescriptiondrug-info.com
Most Recently Shared on May 26, 2011 at 1:05 pm By:
" ive been on a bunch of of meds for bipolar, GAD, and saphris worked the best for me. i lost 30 lbs in 6 we http://PD0.US/F200146
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
drugs.com — “Saphris (asenapine) is used for the treatment of schizophrenia and bipolar I disorder. Saphris information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 1:14 am By:
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asen... http://bit.ly/cBfzbG #drug
FDA Alert: Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions
drugs.com — “FDA Alert: Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions” View full resource at drugs.com
Most Recently Shared on September 1, 2011 at 8:27 pm By:
FDA Alert - Drug Safety Communication: Saphris (asenapine maleate) - Serious Allergic Reactions - http://t.co/yQPehSy
FDA Alert: Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions
drugs.com — “FDA Alert: Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions” View full resource at drugs.com
Most Recently Shared on September 1, 2011 at 9:04 pm By:
Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions: Audience: Psychiatry, P... http://t.co/icYEa9b #FDA
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
Halifax Health
For over 80 years, Halifax Health has provided high-quality health care to East Central Florida.
Advertisement

